Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths E González-López, C Gagliardi, F Dominguez, CC Quarta, ... European heart journal 38 (24), 1895-1904, 2017 | 366 | 2017 |
Role of 99mTc-DPD Scintigraphy in Diagnosis and Prognosis of Hereditary Transthyretin-Related Cardiac Amyloidosis C Rapezzi, CC Quarta, PL Guidalotti, C Pettinato, S Fanti, O Leone, ... JACC: Cardiovascular Imaging 4 (6), 659-670, 2011 | 356 | 2011 |
Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis CC Quarta, SD Solomon, I Uraizee, J Kruger, S Longhi, M Ferlito, ... Circulation 129 (18), 1840-1849, 2014 | 333 | 2014 |
Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy C Rapezzi, CC Quarta, PL Guidalotti, S Longhi, C Pettinato, O Leone, ... European journal of nuclear medicine and molecular imaging 38, 470-478, 2011 | 241 | 2011 |
Cardiac amyloidosis: the great pretender C Rapezzi, M Lorenzini, S Longhi, A Milandri, C Gagliardi, I Bartolomei, ... Heart failure reviews 20, 117-124, 2015 | 218 | 2015 |
Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role S Longhi, CC Quarta, A Milandri, M Lorenzini, C Gagliardi, L Manuzzi, ... Amyloid 22 (3), 147-155, 2015 | 164 | 2015 |
Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies A Milandri, A Farioli, C Gagliardi, S Longhi, F Salvi, S Curti, S Foffi, ... European journal of heart failure 22 (3), 507-515, 2020 | 150 | 2020 |
Identification of TTR-Related Subclinical Amyloidosis With 99mTc-DPD Scintigraphy S Longhi, PL Guidalotti, CC Quarta, C Gagliardi, A Milandri, M Lorenzini, ... JACC: Cardiovascular Imaging 7 (5), 531-532, 2014 | 111 | 2014 |
Coexistence of degenerative aortic stenosis and wild-type transthyretin-related cardiac amyloidosis S Longhi, M Lorenzini, C Gagliardi, A Milandri, A Marzocchi, C Marrozzini, ... JACC: Cardiovascular Imaging 9 (3), 325-327, 2016 | 110 | 2016 |
Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failure C Gagliardi, F Perfetto, M Lorenzini, A Ferlini, F Salvi, A Milandri, ... European journal of heart failure 20 (10), 1417-1425, 2018 | 49 | 2018 |
Cardiac involvement in hereditary-transthyretin related amyloidosis C Rapezzi, S Longhi, A Milandri, M Lorenzini, C Gagliardi, I Gallelli, ... Amyloid 19 (sup1), 16-21, 2012 | 47 | 2012 |
Sex-related risk of cardiac involvement in hereditary transthyretin amyloidosis: insights from THAOS AG Caponetti, C Rapezzi, C Gagliardi, A Milandri, A Dispenzieri, ... Heart Failure 9 (10), 736-746, 2021 | 45 | 2021 |
Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis MU Rauf, PN Hawkins, F Cappelli, F Perfetto, M Zampieri, A Argiro, ... European Heart Journal 44 (24), 2187-2198, 2023 | 37 | 2023 |
Systemic embolism in amyloid transthyretin cardiomyopathy S Vilches, M Fontana, E Gonzalez‐Lopez, L Mitrani, G Saturi, M Renju, ... European journal of heart failure 24 (8), 1387-1396, 2022 | 37 | 2022 |
Analogies and disparities among scintigraphic bone tracers in the diagnosis of cardiac and non-cardiac ATTR amyloidosis C Rapezzi, C Gagliardi, A Milandri Journal of Nuclear Cardiology 26 (5), 1638-1641, 2019 | 34 | 2019 |
Does the etiology of cardiac amyloidosis determine the myocardial uptake of [18F]-NaF PET/CT? C Gagliardi, E Tabacchi, R Bonfiglioli, S Diodato, C Nanni, P Guidalotti, ... Journal of Nuclear Cardiology 24 (2), 746-749, 2017 | 33 | 2017 |
Current patterns of beta‐blocker prescription in cardiac amyloidosis: an Italian nationwide survey G Tini, F Cappelli, E Biagini, B Musumeci, M Merlo, L Crotti, M Cameli, ... ESC Heart Failure 8 (4), 3369-3374, 2021 | 29 | 2021 |
Diagnostic pathways to wild‐type transthyretin amyloid cardiomyopathy: a multicentre network study G Tini, P Milani, M Zampieri, AG Caponetti, F Fabris, A Foli, A Argirò, ... European Journal of Heart Failure 25 (6), 845-853, 2023 | 18 | 2023 |
Prognosis of transthyretin cardiac amyloidosis without heart failure symptoms E Gonzalez-Lopez, L Escobar-Lopez, L Obici, G Saturi, M Bezard, ... Cardio Oncology 4 (4), 442-454, 2022 | 18 | 2022 |
Etiology of amyloidosis determines myocardial 99mTc-DPD uptake in amyloidotic cardiomyopathy S Longhi, R Bonfiglioli, L Obici, C Gagliardi, A Milandri, M Lorenzini, ... Clinical Nuclear Medicine 40 (5), 446-447, 2015 | 11 | 2015 |